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Sciences, Flinders University, Adelaide, Australia; and §Max Planck Institute for Polymer Research, Mainz, GermanyABSTRACT The influenza virus matrix protein 2 (M2) assembles into a tetramer in the host membrane during viral uncoating
and maturation. It has been used as a model system to understand the relative contributions of protein-lipid and protein-protein
interactions to membrane protein structure and association. Here we investigate the effect of lipid chain length on the association
of the M2 transmembrane domain into tetramers using Fo¨rster resonance energy transfer. We observe that the interactions
between the M2 helices are much stronger in 1,2-dilauroyl-sn-glycero-3-phosphocholine than in 1-palmitoyl-2-oleoyl-sn-glyc-
ero-3-phosphocholine bilayers. Thus, lipid chain length and bilayer thickness not only modulate peptide interactions, but could
also be a major determinant of the association of transmembrane helices into functional membrane protein oligomers.INTRODUCTIONMembrane protein folding and association present a chal-
lenging biophysical problem because it is difficult to predict
the structure and stability of a membrane protein or a
membrane protein complex based on its amino acid
sequence (1,2). Although substantial progress has been
made in resolving the folding problem for soluble proteins,
studies of membrane protein folding have lagged behind,
and the factors that determine membrane protein structure
and stability remain to be elucidated (3,4). Nevertheless, it
has become clear that the simplified view of membrane
protein folding as a lateral association of transmembrane
(TM) segments within a slab of hydrocarbon does not
provide an adequate description of the process. In fact, the
bilayer milieu is highly heterogeneous and complex (2),
and the folding process is influenced by both protein-protein
and protein-lipid interactions (5).
Because biological membranes contain a large variety of
lipids, investigators have sought to determine the influence
of lipid composition on the structure and function of folded
membrane proteins (for review see Opekarova´ and Tanner
(6)). For example, the structure and function of themembrane
protein rhodopsin has been shown to depend on the lipid
composition (7,8). However, the role of lipid composition
in the association of TM helices into functional folded
structures is not yet clear, mainly due to a lack of experi-
mental methods that can reveal association thermodynamics
in bilayer environments (3). Indeed, up until a few years ago,
the thermodynamics of membrane protein association was
studied primarily in detergent. Recently, however, new
methods have been established (9–12) and studies of proteinSubmitted March 29, 2010, and accepted for publication July 19, 2010.
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0006-3495/10/09/1810/8 $2.00folding in the native bilayer environment have become
feasible. Here we used one of those methods, Fo¨rster reso-
nance energy transfer (FRET), to investigate the effect of
the lipid chain length on the association of the influenza virus
matrix protein 2 (M2) TM domain into a tetramer.
The influenza virus M2 protein assembles into a tetramer
during viral uncoating and maturation and acts as a highly
selective proton-conducting channel at low pH, and thus
plays an important role in the life cycle of the influenza
A virus (13–15). First, M2 exerts its channel activity in
the endosomes, mediating the acidification of the viral
core and the subsequent release of the viral genome in the
cytoplasm during the uncoating process (16). Second, M2
plays a role in assembly of the amplified viruses and is
believed to mediate the pH equilibration between the acidic
lumen of the trans-Golgi networks (TGNs) and the neutral
cytoplasm during exocytotic transport (14,17,18).
The protein consists of only 97 amino acids and thus is
one of the smallest known selective ion channels (19–21).
Residues 47–97 form the intracellular domain, which plays
a role in pH sensing, viral assembly, and morphogenesis.
The M2 TM domain (residues 22–46) was recently identi-
fied as the minimal functional unit of the protein that is
capable of assembling into a ligand-activated proton
channel (22). Similarly to the full-length protein, the
isolated M2 TM helix has the ability to form tetramers,
conduct protons, and bind amantadine (22–27). The struc-
ture of the tetramer has been determined, revealing
a symmetric (or pseudosymmetric), left-handed, parallel
tetramer bundle (28–35). So far, the ability of M2 TM to
conduct protons has been proved in a variety of artificial
and natural membrane systems, including oocytes (36),
mammalian cells (37), and lipid bilayers (38).
The M2 tetramer has been used as a model system to
elucidate the relative contributions of lipid-protein and
protein-protein interactions to membrane protein folding.
Using electron paramagnetic resonance (EPR) spectros-
copy, Duong-Ly et al. (39) showed that the structure ofdoi: 10.1016/j.bpj.2010.07.026
M2 Tetramer Assembly 1811the M2 tetramer depends on the lipid composition, with the
tilt angle of the helices varying with the thickness
of the bilayer. They proposed that the lipid composition
is the major determinant of the M2 tetramer structure,
with the helix tilt varying between 15 and 38 to minimize
the hydrophobic mismatch between the tetramer and the
lipid bilayer. On the other hand, the helix tilts determined
using solid-state nuclear magnetic resonance (NMR) were
identical in DOPC (33 5 3) and DMPC (37 5 3) (32).
Insights into the effect of lipid composition on the associ-
ation of M2 into tetramers have come from a study utilizing
a thiol-disulfide interchange method (11). This method
yields the oligomeric states of TM helices containing
cysteine residues in the presence of known concentrations
of reduced and oxidized glutathione. For M2, these studies
were possible because the disulfide bonds between cysteines
in positions 17 and 19 have been shown to form, but are
believed to be non-essential for the function of the protein
(40,41). The peptide used in the thiol-exchange method
studies comprised residues 19–46 and contained a single
native Cys residue, thus reversibly forming intermolecular
disulfides upon assembly. The amounts of monomers and
tetramers were determined by high-performance liquid
chromatography (HPLC) and matrix-assisted laser desorp-
tion/ionization time-of-flight (MALDI-TOF), and fitted
to a tetramerization model. This work revealed that the
lateral interactions between the M2 TM helices are modu-
lated by phospholipid acyl chain length and cholesterol
presence. In particular, the association was found to be
stronger in 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocho-
line (POPC) than in 1,2-dilauroyl-sn-glycero-3-phosphocho-
line (DLPC), and became stronger upon cholesterol addition.
However, the thiol exchangemethod is not optimal for inves-
tigations of the relative contributions of protein-protein and
protein-lipid interactions to association thermodynamics
because the readout (% covalent dimer) is sensitive to both
oligomer structure and association thermodynamics. For
instance, if the tetramer structure changes due to the lipid
environment, as has been proposed, the probability for disul-
fide formationmay be changed because the distance between
the cysteines is changed. Thus, some oligomers may not be
detectable by thiol exchange even though they exist.
An alternative method that can provide information about
the association of TM helices in lipid bilayers is FRET
(9,42). As compared with the thiol exchange method,
FRET is much less sensitive to structure and thus allows
us to focus exclusively on the thermodynamics of associa-
tion. Therefore, we revisited the association of M2 into
tetramers using FRET as the detection method. We investi-
gated the effect of the lipid chain length on the association
of M2 into tetramers in bilayers made of DLPC and
POPC. These two bilayers have estimated hydrophobic
core thicknesses of 19.5 A˚ and 26.5 A˚, respectively (43).
For this study we used the TM segment comprising residues
22–46 (i.e., the minimal functional unit of the protein (22)used in structural NMR (31,32) and EPR studies (39)),
which does not include cysteines. Our results confirm that
the lipid composition affects M2 association. However, the
effects observed here are opposite to those observed with
the dithiol exchange method and the longer peptide, in
that the interactions between the M2 helices were stronger
in DLPC than in POPC. Furthermore, the effect of the lipid
chain length of the association of M2 was surprisingly
strong. Therefore, it appears that the lipid chain length
and thus the bilayer thickness not only modulate but could
also be a major determinant of the association of TM helices
into functional oligomers.MATERIALS AND METHODS
Peptide synthesis and purification
The TM domain of M2 of the influenza A virus (SSDPLVVAASIIGILHL
ILWILDRL) was synthesized on a ABI 433A peptide synthesizer using
9-fluorenylmethoxy-carbonyl (Fmoc) chemistry and a double coupling
protocol. A second version of the peptide, CGGGSSDPLVVAASIIGILHL
ILWILDRL, was synthesized to produce a fluorescently labeled version of
M2 for FRET studies. The GGG spacer was included to allow flexibility and
free rotation of the dyes, thereby minimizing the effect of M2 tetramer
structure on the measured FRET efficiency. The peptides were produced
on a CLEAR resin with a substitution level of 0.4 mmol/g on a 0.1 mmol
scale as previously described (44). After the synthesis was completed, the
peptides were removed from the resin with the use of trifluoroacetic acid
and ethane-1,2-dithiol as cleavage and scavenger/swelling agents, respec-
tively. The peptides were lyophilized and purified via reverse-phase
HPLC using a Varian ProStar HPLC, a C2 column, and a water/acetonitrile
gradient. The purified peptides were lyophilized and then dissolved in
1,1,1,3,3,3-hexafluoroisopropanol (HFIP). The correct molecular weights
of the peptides were confirmed using MALDI-TOF mass spectrometry per-
formed with a Voyager DE-STR (Applied Biosystems, Carlsbad, CA). The
peptide concentration was calculated based on measurements of the
absorbance of the single tryptophan residue in the sequence with a Cary
50 spectrophotometer (Varian, Santa Clara, CA).Labeling
After cleavage occurred, the CGGG-M2 TM peptides were labeled at the
single cysteinewith either tetramethylrhodamine (Rh)maleimide orBODIPY
fluorescein (Fl) maleimide (Invitrogen, Carlsbad, CA). For labeling, the
peptide stock in HFIP was dissolved in a mixture of 100 mM sodium phos-
phate buffer, water, and TFE, and mixed with at least a threefold excess of
the reactive dye in methanol. After the mixture was shaken at 4C overnight,
the peptide solutionwas dried and then redissolved inHFIP/water (1:2) before
HPLC purification. The purified peptide was lyophilized and the molecular
weight was determined usingMALDI-TOF. Labeling yields were determined
by comparing dye and peptide concentrations. Briefly, the dye concentration
was determined via UV/Vis spectroscopy and the peptide concentration was
calculated from the circular dichroism (CD) spectra of the peptides in HFIP.
The labeling yields for Fl-CGGGM2 and Rh-CGGGM2 were ~70% and
100%, respectively.Solution CD measurements
The helicity of the peptides was characterized by CD spectrometry with
a Jasco 710 spectropolarimeter (Oklahoma City, OK). Liposomes for CD
measurements were prepared by mixing peptides and lipids (POPC or
DLPC; Alabaster, AL) in organic solvent, followed by removal of theBiophysical Journal 99(6) 1810–1817
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FIGURE 1 CD spectra (mean residue ellipticity versus wavelength) of
the M2 TM domain in HFIP. The CGGG N-terminal tail and the fluorescent
dyes do not perturb the helical secondary structure of M2.
1812 Schick et al.solvent under a stream of nitrogen gas and hydration with 10 mM sodium
phosphate buffer (pH 7, 500 mM NaCl). The final lipid concentration was
0.25 mg/mL and the peptide concentration in the liposomes was 2 mol %
(peptide/lipid ratio ¼ 1:50). The samples were vortexed, freeze-thawed
three times, and sonicated for 2 min before CD spectra were collected.
The lipid background was subtracted from the spectra before the data
were plotted.
Oriented CD
Oriented CD (OCD) spectra were acquired for 2.5 mol % M2 in POPC or
DLPC multilayers. Stocks of peptides in HFIP and lipids in chloroform
were mixed in the appropriate ratio. The solution was deposited dropwise
on a clean round quartz slide, allowing for solvent evaporation after each
drop. The slide was placed in a custom-built humidity chamber and
a drop of water was placed in close proximity before the chamber was
sealed. Eight CD spectra were measured, and the chamber was rotated
around the beam axis in an increment of 45 before each measurement.
The spectra were averaged and corrected for the background CD signal
of lipid multilayers without peptides.200 220 240 260 280
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Fluorescently labeled peptides (Fl-CGGGM2 and Rh-CGGGM2) and lipids
(POPC or DLPC) were mixed in HFIP/chloroform and then dried under
a stream of nitrogen gas. After the samples were redissolved in 10 mM
sodium phosphate buffer (pH 7, 500 mM NaCl), they were vortexed,
freeze-thawed three times, and sonicated in a bath sonicator for at least
2 min. All experiments were performed at room temperature.
In one series of experiments, the peptide concentration (i.e., the peptide/
lipid ratio) was varied while the donor/acceptor ratio was maintained at 1:1.
In a second set of experiments, the samples had different donor/acceptor
ratios but constant peptide/lipid ratios (0.2 mol% peptide). Lipid samples
with only fluorescein-labeled peptides (Fl-CGGGM2) or rhodamine-
labeled peptides (Rh-CGGGM2) served as no-FRET controls. The final
lipid concentration in each sample was 0.25 mg/mL.
Fluorescence spectra were measured in a Fluorolog fluorimeter (Jobin
Yvon, Edison, NJ). Emission spectra were collected from 450 nm to
700 nm with a fixed excitation wavelength at 439 nm. The FRET efficiency
was calculated from measurements of donor intensity at 514 nm according
to the following equation: FRET ¼ (ID  IDA)/ID (where IDA and ID are the
donor intensities at 514 nm in the presence and absence of the acceptor,
respectively). FRETefficiencies measured for varying donor/acceptor-ratios
were fitted to the following equation: FRET ¼ K(1  (1  acceptor_
fraction)m1) (where K is a constant and m is the number of subunits in
the assembled structure (m ¼ 4 for a tetramer)). This is the prediction for
the FRET efficiency in a tetramer with four peptides that are labeled with
either a donor or an acceptor and are mixed randomly (45–47).
To verify the measured FRET efficiencies, in some cases 0.5% Triton
X-100 was added to vesicles with donor- and acceptor-labeled peptides.
Triton X-100 breaks the liposomes and thus unquenches the donor fluores-
cence, yielding the no-FRET control for the sample. After Triton X-100
addition, the samples were mixed and remeasured after 10 min. The
FRET efficiency was calculated according to the following equation:
FRET¼ (IT IDA)/IT (where IT is the donor intensity at 514 nm after Triton
addition, and IDA is the donor intensity at 514 nm before Triton addition).wavelength, nm
FIGURE 2 CD spectra of M2 in DLPC (solid line) and POPC (dashed
line) vesicles. The samples were prepared by premixing peptides and lipids
in HFIP/chloroform, followed by solvent removal and hydration with
10 mM sodium phosphate buffer, pH 7, 500 mM NaCl. The samples
were freeze-thawed three times and sonicated to achieve full equilibration.
The peptide concentration in the vesicles was 2 mol %. The M2 peptides are
helical in POPC and DLPC bilayers.RESULTS AND DISCUSSION
Secondary structure of the M2 TM domain
The secondary structure of M2 TM domains was character-
ized by CD. In Fig. 1 we show the CD spectra of M2 TM
domain, as well as CGGGM2 labeled with the FRET pairBiophysical Journal 99(6) 1810–1817of BODIPY-fluorescein and rhodamine at the N-terminal
cysteine (Fl-CGGGM2 and Rh-CGGGM2) in HFIP. The
three CD spectra are identical, demonstrating that the
CGGG tail and the fluorescent dyes do not affect the helical
secondary structure of M2 in organic solvent. In Fig. 2 we
show the M2 CD spectra in POPC and DLPC liposomes.
Despite spectral distortions due to light scattering (9,48)
and absorption flattening (49–51), these spectra exhibit
minima at 208 nm and 222 nm, and are thus consistent
with a-helical structure.
To probe whether the orientation of the peptides is trans-
membrane, we used OCD. OCD provides an easy way to
assess the disposition of a helix in the bilayer. As shown
by the theoretical OCD spectra in Fig. 3 A, TM helices
exhibit a single minimum around 220–230 nm and a
maximum around 200 nm. In contrast, the OCD spectra of
helices that are parallel to the membrane plane have much
larger amplitudes and minima at ~208 nm and 222 nm
(52,53). Therefore, OCD could be used to assess helix tilt
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FIGURE 3 Oriented CD spectra of M2. (A) Theoretical OCD helix
spectra. (B) Experimental OCD spectra of M2 in oriented DLPC (dashed
line) and POPC (solid line) multilayers. The peptide was mixed with the
lipids in HFIP/chloroform, deposited dropwise on a quartz slide, and
hydrated to form multilayers. The experimental spectra are the average of
eight discrete scans and are corrected for the lipid background (see Mate-
rials andMethods). Although the average tilt angle in POPCmay be slightly
higher, the spectra suggest that the peptides are predominantly transmem-
brane in both bilayers.
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FIGURE 4 Optical densities measured for liposome solutions (dashed
line) and OCD samples (solid line). Although the absorbance of liposome
samples sharply increases below 210 nm, OCD samples are nearly trans-
parent above 200 nm.
M2 Tetramer Assembly 1813with respect to the bilayer normal. However, the precision of
such measurements is rather low (10–20 (44,54)) compared
to solid-state NMR (a few degrees). Experimental limita-
tions arise because the amplitude of the OCD signal for
TM helices is low and is similar to the OCD amplitude of
the lipid background. Furthermore, the OCD signal for the
lipids, which are also chiral, is affected by the peptide-
induced bilayer perturbations. Despite these limitations,
however, OCD can reliably distinguish a TM helix that
transverses the bilayer from a helix that is parallel to the
bilayer surface, because of the large differences in both
shape and amplitude of the respective spectra (Fig. 3 A).
In Fig. 3 B we show the OCD spectra of M2 in POPC and
DLPC. As described in Materials and Methods, the OCD
samples were hydrated multilayers that were perpendicular
to the beam. The experimental spectrum of M2 in DLPC in
Fig. 3 B has a low amplitude and a single minimum around
230 nm, indicating that the M2 TM domain is normal to the
DLPC bilayer. The spectrum in POPC is similar, although
the 208 nm minimum is also visible. Although the latter
may be indicative of a slight tilt, a comparison between
the theoretical and experimental spectra in Fig. 3 suggests
that this tilt does not exceed ~20. Alternatively, the differ-ence between the two spectra may be due to differences in
the oligomerization state of the peptides, or to the presence
of a small non-TM M2 fraction in POPC. Yet, the OCD
spectra suggest that the M2 peptides span both POPC and
DLPC bilayers.
A question may arise as to whether the OCD spectra
are affected by optical absorbance or light scattering. We
therefore measured the optical densities of the OCD and
liposome samples, and we show the spectra in Fig. 4.
Whereas the absorbance of the liposome samples sharply
increases below 210 nm, leading to a decrease in the ampli-
tude and hence a distortion of the solution CD spectrum in
this region (see Fig. 2), the OCD sample is nearly trans-
parent over the wavelength range of interest. For example,
the optical density of the OCD sample is ~0.1 at 208 nm,
indicating that the transmittance is 80% at this wavelength.
Thus, the OCD spectrum is not significantly affected by
absorbance or light scattering, and provides reliable infor-
mation about M2 disposition in the bilayers.Association of M2 in POPC and DLPC bilayers
For the FRET experiments, the M2 TM domain was labeled
with the FRET pair of BODIPY-fluorescein/rhodamine
(Fl/Rh). To ensure that the FRET efficiency did not depend
on the orientation of the dyes or on the M2 tetramer struc-
ture, the dyes were attached to the N-terminal Cys, and
a GGG spacer was used to allow free rotation of the dyes.
Fig. 5 shows typical emission spectra of liposomes
containing 1), Fl-CGGGM2 (donor only, solid line); 2),
Rh-CGGGM2 (acceptor only, dotted line); or 3), both Fl-
CGGGM2 and Rh-CGGGM2 (donorþacceptor, dashed
line). As discussed in Materials and Methods, the FRETeffi-
ciency is calculated from the decrease in donor emission at
514 nm in the presence of the acceptor. Unlike detergent
samples, which allow easy equilibration of peptides and
lipids, the donor and the donorþacceptor lipid samplesBiophysical Journal 99(6) 1810–1817
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FIGURE 5 Emission spectra of Fl/Rh-labeled CGGGM2 in (A) DLPC
and (B) POPC vesicles. The excitation was fixed at 439 nm such that
only fluorescein was directly excited. The emission was scanned from
450 nm to 700 nm. FRET efficiency is calculated from the decrease in fluo-
rescein emission at 514 nm in the presence of the acceptor rhodamine.
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FIGURE 6 Measured FRET efficiency as a function of the peptide/lipid
ratio. The ratio of donor-labeled to acceptor-labeled peptides was kept
constant at 1:1. Solid symbols (squares and circles): FRET efficiency
measured in DLPC vesicles, pH ¼ 7. Solid squares: FRET was measured
by comparing two samples with identical Fl-CGGGM2 concentrations,
with and without acceptor. Solid circles: FRETwas measured by acquiring
spectra before and after Triton addition, which dequenches the donor fluo-
rescence. Crossed diamonds: FRET measured in POPC vesicles, pH ¼ 7.
Open triangles: FRET in POPC vesicles, pH ¼ 8.6. Solid line: FRET due
to random colocalization (proximity) of donors and acceptors. Although
the FRETefficiency in POPC vesicles is similar to that expected for random
fluorophore proximity, the FRET efficiency in DLPC vesicles is much
higher.
1814 Schick et al.have to be prepared independently from stocks of lipids and
labeled peptides (9). Although the donor concentration must
be exactly the same in these two samples, the low solubility
of the hydrophobic TM helices can introduce sample-to-
sample variations in protein concentrations, leading to
possible errors in the measured FRET efficiencies (55).
That is why we use an alternative approach, as introduced
here, to calculate FRET. Briefly, we add 0.5% Triton
X-100 to measured samples with donor- and acceptor-
labeled peptides. Triton X-100 breaks the liposomes and
thus unquenches the donor fluorescence, yielding a no-
FRET control with the exact donor concentration.
In Fig. 6 we show the measured FRET efficiency as
a function of total peptide concentration in liposomes
made of DLPC and POPC (donor/acceptor ratio ¼ 1).
Some of the FRET efficiencies in DLPC were calculated
by comparing two samples of identical donor concentration
(solid squares), whereas others (solid circles) were calcu-
lated after the addition of Triton. The two methods yielded
very similar results, suggesting that the Triton addition
method is a valid approach for measuring FRET efficiencies
in liposomes.
As shown in Fig. 6, measurements in POPC yielded
a much lower FRET efficiency as compared to DLPC.
Note that the same peptide stocks were used in the POPC
and DLPC experiments. Therefore, the difference in theBiophysical Journal 99(6) 1810–1817measured FRET efficiency is due to the different lipid envi-
ronments and reflects differences in the association of the
peptides in the two bilayers. We thus conclude that the
propensity for M2 association is higher in DLPC than in
POPC, in contrast to previous findings for a longer M2
TM segment (11).
Next, we investigated how the measured FRET efficien-
cies compare with the case in which there are no specific
interactions between the peptides. Even in this case, FRET
arising from random colocalization of donors and acceptors
(proximity effects) will be recorded (9,56,57). In our exper-
iments we used a low peptide concentration, and the average
distances between the peptides always exceeded the Fo¨rster
radius for Fl/Rh (55 A˚); however, because the peptides
diffuse in the bilayers, FRET can occur if an acceptor comes
in contact with a donor. The FRET efficiency due to prox-
imity effects can be estimated computationally (58). The
calculation of proximity FRET as the average of 1000
different acceptor configurations is shown in Fig. 6 for
R0¼ 55 A˚, the Forster radius for the Fl/Rh FRET pair (solid
line). The solid curve is similar to the experimental data for
POPC, suggesting that proximity effects can describe the
observed FRET signal, and therefore interactions between
M2 are very weak or nonexistent in POPC.
Previous structural studies were carried out under the
assumption that M2 is fully tetrameric. NMR studies were
performed for M2 concentrations in the range from
3–12 mol % (29–32), whereas in EPR studies the concentra-
tion was lower: 1 mol % protein (39). The assumption of
tetramers is consistent with the high FRET efficiency we
M2 Tetramer Assembly 1815observe in DLPC bilayers. However, the data in Fig. 6
suggest that M2 is monomeric in POPC up to concentrations
of 0.5 mol %. The EPR studies were performed at pH 8.6,
and therefore we sought to determine whether increasing
the pH to 8.6 would affect the association in POPC. The
measured FRET efficiencies in POPC at pH 8.6 are shown
in Fig. 6 (open triangles). The results obtained at pH 7
and 8.6 are similar, and there are no indications of specific
M2 interactions in POPC at pH 8.6.
Next, we measured FRET efficiencies in DLPC for
a constant peptide/lipid ratio and a varying donor/acceptor
ratio (Fig. 7, solid circles). A linear dependence of the energy
transfer on the acceptor mole ratio is indicative of sequence-
specific dimer formation (9,45,46,59). Deviation from line-
arity indicates the formation of higher-order aggregates
(46). A fit describing tetramer formation is shown in Fig. 7
(solid line) and provides an adequate description of the
DLPC data. Overall, the data in Figs. 6 and 7 demonstrate
thatM2 ismonomeric in POPC but forms tetramers inDLPC.
Finally, it may seem surprising that the monomeric M2
peptide spans the POPC bilayer, with some hydrophilic
amino acids in direct contact with lipids. During the last
decade, research has demonstrated that hydrophilic or
charged amino acids can insert into bilayers if they are
driven by the hydrophobicity of the neighboring amino
acids (54,61,62). The M2 sequence is rich in leucines and
isoleucines, which are predicted to drive the stable insertion
of the helix into the bilayer (63).CONCLUSIONS
In this study we investigated the association of the TM
domain of M2 in lipid bilayers composed of POPC and
DLPC with hydrophobic core thickness of 26.5 A˚ and
19.5 A˚, respectively. The M2 sequence used comprised resi-
dues 22–46, which have been identified as the smallest func-0.0 0.2 0.4 0.6 0.8
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FIGURE 7 Measured FRET efficiency for M2 in DLPC vesicles as
a function of the acceptor mole fraction. The peptide/lipid ratio was kept
constant at 0.2 mol % peptide. The data (solid circles) follow the equation
FRET ¼ K(1  (1  acceptor_fraction)m1) with m ¼ 4, describing
tetramer formation.tional part of the M2 full-length protein. The same sequence
was previously used for structural NMR and EPR studies.
Here, we studied M2 association into tetramers using
FRET, and we observed that the lipid chain length and there-
fore the thickness of the bilayer modulates the association of
the M2 peptide. The effect was surprisingly strong, and the
data suggest association into tetramers in DLPC but no
interactions in POPC. Overall, this work demonstrates that
the bilayer thickness not only modulates but can also
make a major contribution to the folding and association
of membrane proteins.
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